The poor efficacy and tolerability of conventional antipsychotic treatment in schizophrenia, together with discovery of …

individuals diagnosed with schizophrenia or episodic mood disorders with the implementation of Prepaid Mental Health Plans (PMHPs … enrolled in Medicaid. Individuals were required to have at least two diagnoses of schizophrenia, episodic mood disorders … post-PMHP implementation: penetration; adherence; Medicaid expenditures for antipsychotics; polypharmacy (multiple …

Schizophrenia continues to be a major healthcare expenditure in our society. Antipsychotic drugs were introduced in the … indirect costs of schizophrenia were estimated to total $US33 billion in 1990. Prior to the approval by the US Food and Drug … Administration (FDA) of clozapine in 1989, no new antipsychotics had been introduced in the US for at least 10 years. Clozapine was …

Relapse of schizophrenia due to poor medication adherence is a major preventable source of psychiatric morbidity. This …

Objective: To estimate resource utilisation and direct costs of treatment for patients with schizophrenia in Italian … National Health Service (INHS). Patients: 702 patients with a diagnosis of schizophrenia or other psychotic disorders, defined …: The mean direct cost of patients with schizophrenia in the 2-month observation period was 2 234 475 Italian lire [L] (1154 …

schizophrenia. Design and setting: An international, multicentre, double-blind, prospective study. To facilitate economic … mental disorders, 4th edition (DSM-IV) diagnosis of schizophrenia, schizoaffective disorder or schizophreniform disorder were …

Schizophrenia is a chronic disease that typically manifests during adolescence and early adulthood. Treatment of this … for schizophrenia include both pharmacologic and psychosocial interventions, with antipsychotic therapy (typicals or …-line treatments for patients with newly diagnosed schizophrenia. The newer atypical antipsychotic agents have a lower propensity to …

antipsychotics in a naturalistic outpatient setting. Methods: The pan-European SOHO study is a 3-year, prospective, outpatient … other antipsychotics (risperidone, quetiapine, amisulpride, clozapine and oral or depot typical antipsychotics). Results: A … threshold. Comparing olanzapine with oral and depot typical antipsychotics, the incremental cost was Lstg 849 and Lstg 1106 per …

Schizophrenia is a chronic disease characterized by periods of relative stability interrupted by acute episodes (or … techniques that have been used in schizophrenia: decision trees, (cohort and micro-simulation) Markov models and discrete event … schizophrenia treatments, a discrete event simulation model is best suited to accurately capture all of the relevant …

. Methods: We analysed data on earnings and other characteristics from the Schizophrenia Care and Assessment Program (SCAP), a 3 …-year longitudinal study (with data collection during the years 1997-2003) of 2327 adults with schizophrenia (including … connected with employment and labour supply in patients with schizophrenia, and both may be improved through use of atypicals. …